Future Financial Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Future Financial Wealth Management's MRNA Position: Q2 2022 in Review
Future Financial Wealth Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5 shares — an estimated $1K sold.
Future Financial Wealth Management first reported a position in MRNA in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.
- Future Financial Wealth Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
- Future Financial Wealth Management sold 5 Moderna shares in Q2 2022, an estimated $1K.
- Future Financial Wealth Management first reported a position in Moderna in Q4 2021 and held it in 2 quarters.
- Future Financial Wealth Management's Moderna position peaked at $1K in Q1 2022.
- 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.
Based on Future Financial Wealth Management's 13F filing for Q2 2022, filed 5 Jul 2022.